Some numbers make you stop for a second. This is one of them. If you had invested $100,000 AUD in Pro Medicus (PME.AX) in 2006 and reinvested every dividend, your annual dividend income in 2026 would be $36,000 AUD.
The ending income stream is unusually large. A yield on cost of 36.00% would feel big even to experienced dividend investors. In simple English, this page asks a very human question. What would twenty years of patience have felt like if every dividend payment had been pushed back into the same stock through a DRIP plan?
Twenty years is a long time. It includes bull markets, painful drawdowns, and many moments when holding felt boring or uncomfortable. This page focuses on the full reinvestment case because that is where the compounding story becomes real. Scenario 1 is still useful as a reference point, but Scenario 2 is the one that shows how the share count can grow instead of staying frozen.
In Australia, dividend culture is deeply woven into how many investors think about wealth, income, and long-run ownership. For this study, the clock starts in 2006 and ends in April 2026. The final number does not claim the next twenty years will look the same. It simply shows what happened when dividend payments were not spent, but recycled back into ownership.
- Initial investment: $100,000 AUD
- Current annual dividend income with full DRIP: $36,000 AUD
- Yield on cost: 36.00%
- Time period: January 2006 to April 2026
Scenario 1 vs Scenario 2
Investors usually ask the same follow-up question after seeing a result like this. Was the final income number driven by the business alone, or by reinvestment? The honest answer is both. The company still had to pay and grow dividends, but reinvestment changed the share count. That is why the DRIP case matters so much.
| Factor | Scenario 1: no DRIP | Scenario 2: full DRIP |
|---|---|---|
| Starting capital | $100,000 AUD | $100,000 AUD |
| Dividend handling | Paid out as cash and not reinvested | Every dividend used to buy more shares |
| Share count over time | Stays close to the original purchase | Grows as each payment buys more shares |
| Annual income in 2026 | Lower than the DRIP case | $36,000 AUD |
| Core lesson | Useful for spending, but weaker compounding | Stronger compounding through share accumulation |
That difference is the emotional heart of the page. In the no-DRIP case, dividends are pleasant cash payments. In the DRIP case, those same payments become fuel. They buy more shares, and those extra shares then help create larger future payments. It is a slow loop, but over twenty years it can feel surprisingly powerful.
How the numbers were calculated
The starting point is the earliest 2006 trading window used by the study. The analysis uses split-adjusted prices and dividend history so the final income figure is comparable across time.
For the DRIP case, each dividend payment is assumed to be reinvested back into the same stock at the ex-dividend date or the nearest available close. That means the share count grows over time rather than staying fixed.
The page headline uses the full reinvestment result because the uploaded study specifically flags the Y value as current annual dividend income today from a 2006 investment with share accumulation. This page stays faithful to that idea and does not mix in capital gains.
That last point matters. The number on this page is about income, not total wealth. Price returns may be important in real life, but the center of this page is dividend cash flow in 2026.
- Purchase window: earliest 2006 trading period used by the study
- Data basis: split-adjusted price history and dividend history
- Reinvestment assumption: dividends reinvested on ex-date or nearest close
- Focus: income only, not price appreciation
The compounding story behind Pro Medicus
Pro Medicus did not need to produce drama every year for this story to work. It only needed enough business strength to keep paying, enough resilience to survive rough periods, and enough time for reinvested dividends to buy extra shares. That is why the result can feel emotional. The magic is not one big moment. The magic is repetition.
By 2026, the annual income stream reaches $36,000 AUD, which works out to about $3,000 per month. For some people, that is a nice side income. For others, it is a serious contribution to living expenses. Either way, the number feels more tangible when you convert it into monthly cash flow.
Another part of the story is behavior. Many investors interrupt compounding without meaning to. They sell too early, chase the next hot theme, or treat small dividends like loose change. This type of lookback shows why those small payments mattered. Every reinvested payment bought a little more ownership, and a little more ownership helped create a larger future payment.
The benchmark for this market is the S&P/ASX 200. That benchmark matters because it gives context, but it does not erase the fact that single-stock outcomes can be very personal. Some names become quiet workhorses. Others surprise even patient investors. This page exists because people do not just want a generic market average. They want to understand how one decision made long ago could have changed income today.
Visual checkpoints
This module keeps the visual section simple and crawlable. Instead of hiding the story behind a chart image, it shows the compounding journey in plain text that both people and search engines can read easily.
| Period | What the investor likely felt |
|---|---|
| 2006 | The study begins with an initial purchase of $100,000 AUD. Income starts from zero because the position is brand new. |
| 2008 to 2009 | Early market stress tests conviction. This is where many long-term stories are either abandoned or allowed to keep compounding. |
| 2011 to 2015 | Repeated dividend payments begin to matter more because they are buying extra shares instead of being spent. |
| 2016 to 2020 | The effect becomes easier to feel. Each new payment is now supported by a larger share base than at the start. |
| 2021 to 2026 | The compounding story reaches its current end point, with annual dividend income rising to $36,000 AUD. |
If you like visuals, the important picture is easy to imagine. The line does not move straight up. It wiggles. It slows down. It speeds up. But the broader direction comes from one simple thing: the share count becomes larger than it was at the start, and the income stream grows on top of that larger base.
Risks and important notes
Past performance does not guarantee future dividend growth. A company can change. Its industry can change. Management can shift priorities. A generous payout history does not make a future cut impossible.
Australian shares can produce strong income, but investors still need to watch cyclical profit swings, payout sustainability, and valuation risk. Taxes, withholding rules, and account structure can also change what an investor actually keeps after the dividend is paid.
This page also ignores price volatility in the headline result. That keeps the story clean, but real investors still need to live through drawdowns, scary headlines, and long stretches where sentiment turns negative. Compounding only helps those who can stay in the seat.
There is also a human risk that does not show up in spreadsheets. Staying invested for twenty years is emotionally hard. Many people cannot do it. That does not make the math less real, but it does make the real-world journey harder than the final table might suggest.
Conclusion
Looking back at Pro Medicus from 2006 to 2026 reminds us that dividend investing is not just about picking a stock with a nice yield today. It is about what happens when business quality, time, and reinvestment meet each other year after year. In this case, that path leads to $36,000 AUD in annual dividend income and a yield on cost of 36.00%.
If that number excites you, the next step is not to copy the past blindly. The next step is to study why this worked, compare it with other long-run dividend stories, and stay honest about risk, taxes, and valuation. That is where better decisions start.